Selected Articles: Pfizer Works to Fast-Track More Vaccines for Pregnant Moms, Despite Mounting Evidence Rushed COVID Shots Harmed Babies
By , November 10, 2022
Buoyed by the successful global marketing of its COVID-19 vaccines, Pfizer is teeing up to dominate the maternal vaccine market even as OB-GYNs on the front lines of maternal care sound the alarm about the COVID-19 shots’ infanticidal fallout.
More Thoughts on the Stolen 2022 Election
By , November 11, 2022
In Maricopa County Arizona it appears that the Democrats’ attempt to steal the election is being explained away as a “printer issue.” Somehow the machines that worked in the primaries “malfunctioned” in the election.
Is Turkey Changing Course in Idlib?
By , November 11, 2022
The Syrian Arab Army (SAA) and Russian warplanes shelled positions of Hayat Tahrir al-Sham (HTS), the Al Qaeda affiliate in Syria, on November 6 in Idlib province. Some of the terrorists killed were: Abdul Minam Muhati, Radwan Hussain Muhayer, Abu Dawoud al-Filistini, Mohammad Ali al-Kadour, Abu Hussein al-Raddad, Abu Hajat al-Chad, Amro abu Layth al-Askandarani, and Mohammed Suliaman al-Ali.
Brain Inflammation and the mRNA Vaccines
By , November 10, 2022
Three large insurance databases showed sharp increases in cases of severe brain inflammation after the Covid mRNA shots, according to a new peer-reviewed paper. People who received the Pfizer jab or booster had a 40 to 70 percent higher chance over the next six weeks of encephalitis or encephalomyelitis. The Moderna jab carried an even higher risk after the second primary dose or a booster.
Pfizer’s COVID Cash Powers a ‘Marketing Machine’ on the Hunt for New Supernovas
By , November 10, 2022
The company has reaped nearly $100 billion from selling covid-19 vaccines and treatments to U.S. taxpayers and foreign governments. With that windfall, it plans to get richer, sinking the cash into developing and marketing potential blockbusters for conditions like migraines, ulcerative colitis, prostate cancer, sickle cell disease, and obesity.
By , November 10, 2022
In this issue of the Report, we have an exclusive interview with Alexandria (Sasha) Latypova, MBA, a former pharmaceutical executive, and independent analyst. Her prior reports on TrialSite News that deaths reported in VAERS after COVID-19 vaccination are not randomly distributed according to manufacturing lots as they are with influenza vaccines. Instead, they are aggregated in specific “hot lots.”
Apple Is Tracking You Even When Its Own Privacy Settings Say It’s Not, New Research Says
By , November 10, 2022
For all of Apple’s talk about how private your iPhone is, the company vacuums up a lot of data about you. iPhones do have a privacy setting that is supposed to turn off that tracking. According to a new report by independent researchers, though, Apple collects extremely detailed information on you with its own apps even when you turn off tracking, an apparent direct contradiction of Apple’s own description of how the privacy protection works.
Energy Bills in Europe Are 90% Higher Than Last Year
By , November 10, 2022
Electricity and gas prices are soaring across Europe, with bills close to double from last year in most European capitals, according to new data from the Household Energy Price Index—a monthly tracker of energy prices for households across 33 European capitals, including the 27 EU member states and several non-members.
Let’s be Clear: If World War III Happens It Will be the Result of Choices Made by the US Empire
By , November 10, 2022
The commander of the US nuclear arsenal has stated unequivocally that the war in Ukraine is just a warmup exercise for a much larger conflict that’s already in the mail.
Russia’s Tactical Retreat from Right-bank Kherson Region – Victory for Kiev?
By , November 10, 2022
On November 9, Russian High Command announced it will retreat from the right-bank areas of the Kherson oblast (region). The current commander of Russia’s special military operation in Ukraine, Army General Sergei Surovikin, announced the plan in a report to Defence Minister Sergei Shoigu.
